Form 8-K - Current report:
SEC Accession No. 0001193125-24-277086
Filing Date
2024-12-12
Accepted
2024-12-12 16:28:58
Documents
63
Period of Report
2024-12-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d191675d8k.htm   iXBRL 8-K 51608
2 EX-99.1 d191675dex991.htm EX-99.1 29686
3 EX-99.2 d191675dex992.htm EX-99.2 62496
7 GRAPHIC g191675dsp013.jpg GRAPHIC 254842
8 GRAPHIC g191675dsp014.jpg GRAPHIC 106751
9 GRAPHIC g191675dsp015.jpg GRAPHIC 82691
10 GRAPHIC g191675dsp016.jpg GRAPHIC 181031
11 GRAPHIC g191675dsp017.jpg GRAPHIC 181671
12 GRAPHIC g191675dsp018.jpg GRAPHIC 136064
13 GRAPHIC g191675dsp019.jpg GRAPHIC 159200
14 GRAPHIC g191675dsp020.jpg GRAPHIC 192620
15 GRAPHIC g191675dsp021.jpg GRAPHIC 166770
16 GRAPHIC g191675dsp022.jpg GRAPHIC 108128
17 GRAPHIC g191675dsp023.jpg GRAPHIC 165407
18 GRAPHIC g191675dsp024.jpg GRAPHIC 178112
19 GRAPHIC g191675dsp025.jpg GRAPHIC 226396
20 GRAPHIC g191675dsp026.jpg GRAPHIC 182745
21 GRAPHIC g191675dsp027.jpg GRAPHIC 148501
22 GRAPHIC g191675dsp028.jpg GRAPHIC 163962
23 GRAPHIC g191675dsp029.jpg GRAPHIC 142572
24 GRAPHIC g191675dsp030.jpg GRAPHIC 112159
25 GRAPHIC g191675dsp031.jpg GRAPHIC 91657
26 GRAPHIC g191675dsp032.jpg GRAPHIC 140284
27 GRAPHIC g191675dsp033.jpg GRAPHIC 171966
28 GRAPHIC g191675dsp034.jpg GRAPHIC 199552
29 GRAPHIC g191675dsp035.jpg GRAPHIC 147011
30 GRAPHIC g191675dsp036.jpg GRAPHIC 165888
31 GRAPHIC g191675dsp037.jpg GRAPHIC 167309
32 GRAPHIC g191675dsp038.jpg GRAPHIC 156762
33 GRAPHIC g191675dsp039.jpg GRAPHIC 165045
34 GRAPHIC g191675dsp040.jpg GRAPHIC 150036
35 GRAPHIC g191675dsp041.jpg GRAPHIC 165150
36 GRAPHIC g191675dsp042.jpg GRAPHIC 171112
37 GRAPHIC g191675dsp043.jpg GRAPHIC 163404
38 GRAPHIC g191675dsp044.jpg GRAPHIC 131190
39 GRAPHIC g191675dsp045.jpg GRAPHIC 196869
40 GRAPHIC g191675dsp046.jpg GRAPHIC 154365
41 GRAPHIC g191675dsp047.jpg GRAPHIC 143384
42 GRAPHIC g191675dsp048.jpg GRAPHIC 172647
43 GRAPHIC g191675dsp049.jpg GRAPHIC 120639
44 GRAPHIC g191675dsp050.jpg GRAPHIC 97134
45 GRAPHIC g191675dsp051.jpg GRAPHIC 227881
46 GRAPHIC g191675dsp052.jpg GRAPHIC 164072
47 GRAPHIC g191675dsp053.jpg GRAPHIC 166458
48 GRAPHIC g191675dsp054.jpg GRAPHIC 131605
49 GRAPHIC g191675dsp055.jpg GRAPHIC 317362
50 GRAPHIC g191675dsp057.jpg GRAPHIC 107510
51 GRAPHIC g191675dsp058.jpg GRAPHIC 224251
52 GRAPHIC g191675dsp7.jpg GRAPHIC 2861
53 GRAPHIC g191675g08g08.jpg GRAPHIC 207564
54 GRAPHIC g191675g10g10.jpg GRAPHIC 182243
  Complete submission text file 0001193125-24-277086.txt   10891966

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rptx-20241212.xsd EX-101.SCH 2512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20241212_lab.xml EX-101.LAB 18666
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20241212_pre.xml EX-101.PRE 11673
65 EXTRACTED XBRL INSTANCE DOCUMENT d191675d8k_htm.xml XML 3906
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 241545245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)